The development of dialysis by early pioneers such as Willem Kolff and Belding Scribner set
in motion several dramatic changes in the epidemiology, economics and ethical frameworks …

The global nephrology community recognizes the need for a cohesive strategy to address
the growing problem of end-stage kidney disease (ESKD). In March 2018, the International …

Background Variability in ultrafiltration influences prescriptions and outcomes in patients
with kidney failure who are treated with peritoneal dialysis. Variants in AQP1, the gene that …

Peritoneal fibrosis is characterized by abnormal production of extracellular matrix proteins
leading to progressive thickening of the submesothelial compact zone of the peritoneal …

Rationale & Objective Peritoneal dialysis (PD)-associated peritonitis is a significant PD-
related complication. We describe the likelihood of cure after a peritonitis episode, exploring …

Background Biocompatible peritoneal dialysis (PD) solutions, including neutral pH, low
glucose degradation product (GDP) solutions and icodextrin, have previously been shown to …

Secondary, AA, amyloidosis is a rare systemic complication that can develop in any long-
term inflammatory disorder, characterized by the pathogenic extracellular deposition of …

Diabetic nephropathy is highly correlated with the occurrence of other complications of type
1 diabetes (T1D) and type 2 diabetes (T2D) mellitus; for example, hypertension with …

Peritoneal dialysis (PD) is an efficient renal replacement therapy for patients with end-stage
renal disease. Even if it ensures an outcome equivalent to hemodialysis and a better quality …

Mesothelial cells are specific epithelial cells lining the serosal cavity and internal organs.
Nonetheless, few studies have explored the possibility to culture mesothelial cells in a …